Search results
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 1 hour ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
The Conversation· 10 hours agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU announcement was preceded by an application from AstraZeneca ...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 1 day agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 2 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WSAU Wausau· 2 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 2 days agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker ...
The path to a better Tuberculosis vaccine runs through Montana
Daily Montanan via Yahoo News· 4 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 6 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 6 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...